AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: van Duijnhoven, EM Boots, JMM Christiaans, MHL Wolffenbuttel, BHR Van Hooff, JP
Citation: Em. Van Duijnhoven et al., Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study, J AM S NEPH, 12(3), 2001, pp. 583-588

Authors: Vrijhoef, HJM Spreeuwenberg, C Eijkelberg, IMJG Wolffenbuttel, BHR van Merode, GG
Citation: Hjm. Vrijhoef et al., Adoption of disease management model for diabetes in region of Maastricht, BR MED J, 323(7319), 2001, pp. 983-985

Authors: Vrijhoef, HJM Diederiks, JPM Spreeuwenberg, C Wolffenbuttel, BHR
Citation: Hjm. Vrijhoef et al., Substitution model with central role for nurse specialist is justified in the care for stable type 2 diabetic outpatients, J ADV NURS, 36(4), 2001, pp. 546-555

Authors: Yusuf, S Gerstein, H Hoogwerf, B Pogue, J Bosch, J Wolffenbuttel, BHR Zinman, B
Citation: S. Yusuf et al., Ramipril and the development of diabetes, J AM MED A, 286(15), 2001, pp. 1882-1885

Authors: Blaak, EE Wolffenbuttel, BHR Saris, WHM Pelsers, MMAL Wagenmakers, AJM
Citation: Ee. Blaak et al., Weight reduction and the impaired plasma-derived free fatty acid oxidationin type 2 diabetic subjects, J CLIN END, 86(4), 2001, pp. 1638-1644

Authors: Wolffenbuttel, BHR Elving, LD Maassen, JA Bravenboer, B Hoekstra, JBL
Citation: Bhr. Wolffenbuttel et al., to: Waldhausl W (2001) editorial: Finally we have arrived in a new millennium. Diabetologia 44 : 1-2, DIABETOLOG, 44(7), 2001, pp. 923-923

Authors: Oranje, WA Sels, JPJE Rondas-Colbers, GJWM Lemmens, PJMR Wolffenbuttel, BHR
Citation: Wa. Oranje et al., Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients, CLIN CHIM A, 311(2), 2001, pp. 91-94

Authors: Wolffenbuttel, BHR Gomis, R Squatrito, S Jones, NP Patwardhan, RN
Citation: Bhr. Wolffenbuttel et al., Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients, DIABET MED, 17(1), 2000, pp. 40-47

Authors: Lauritzen, T Griffin, S Borch-Johnsen, K Wareham, NJ Wolffenbuttel, BHR Rutten, G
Citation: T. Lauritzen et al., The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people withType 2 diabetes detected by screening, INT J OBES, 24, 2000, pp. S6-S11

Authors: Sels, JPJE Wouters, RMME Lamers, R Wolffenbuttel, BHR
Citation: Jpje. Sels et al., Pitfall of the accessory spleen, NETH J MED, 56(4), 2000, pp. 153-158

Authors: Blaak, EE Wagenmakers, AJM Glatz, JFC Wolffenbuttel, BHR Kemerink, GJ Langenberg, CJM Heidendal, GAK Saris, WHM
Citation: Ee. Blaak et al., Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle, AM J P-ENDO, 279(1), 2000, pp. E146-E154

Authors: van Maanen, JMS Albering, HJ de Kok, TMCM van Breda, SGJ Curfs, DMJ Vermeer, ITM Ambergen, AW Wolffenbuttel, BHR Kleinjans, JCS Reeser, HM
Citation: Jms. Van Maanen et al., Does the risk of childhood diabetes mellitus require revision of the guideline values for nitrate in drinking water?, ENVIR H PER, 108(5), 2000, pp. 457-461

Authors: Graal, MB Wolffenbuttel, BHR
Citation: Mb. Graal et Bhr. Wolffenbuttel, The use of sulphonylureas in the elderly, DRUG AGING, 15(6), 1999, pp. 471-481

Authors: Crijns, FRL Wolffenbuttel, BHR De Mey, JGR Boudier, HAJS
Citation: Frl. Crijns et al., Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling, AM J P-HEAR, 45(5), 1999, pp. H1672-H1677

Authors: Blaak, EE Saris, WHM Wolffenbuttel, BHR
Citation: Ee. Blaak et al., Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM, INT J OBES, 23(4), 1999, pp. 411-418

Authors: Engels, W van Bilsen, M Wolffenbuttel, BHR van der Vusse, GJ Glatz, JFC
Citation: W. Engels et al., Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid binding protein content in liver, heart and kidney of the diabetic rat, MOL C BIOCH, 192(1-2), 1999, pp. 53-61

Authors: Wolffenbuttel, BHR
Citation: Bhr. Wolffenbuttel, Repaglinide - a new compound for the treatment of patients with type 2 diabetes, NETH J MED, 55(5), 1999, pp. 229-234

Authors: Wolffenbuttel, BHR Sels, JPJE Rondas-Colbers, GJWM Menheere, PPCA
Citation: Bhr. Wolffenbuttel et al., Prognostic factors for successful insulin therapy in subjects with type 2 diabetes, NETH J MED, 54(2), 1999, pp. 63-69

Authors: Wolffenbuttel, BHR Landgraf, R
Citation: Bhr. Wolffenbuttel et R. Landgraf, A 1-year multicenter randomized double-blind comparison of repaglinide andglyburide for the treatment of type 2 diabetes, DIABET CARE, 22(3), 1999, pp. 463-467

Authors: Oranje, WA Rondas-Colbers, GJWM Swennen, GNM Jansen, H Wolffenbuttel, BHR
Citation: Wa. Oranje et al., Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes, DIABET CARE, 22(12), 1999, pp. 2083-2084

Authors: Van Maanen, JMS Albering, HJ Van Breda, SGJ Curfs, DMJ Ambergen, AW Wolffenbuttel, BHR Kleinjans, JCS Reeser, HM
Citation: Jms. Van Maanen et al., Nitrate in drinking water and risk of childhood diabetes in the Netherlands, DIABET CARE, 22(10), 1999, pp. 1750-1750

Authors: Blaak, EE Kemerink, GJ Pakbiers, MTW Wolffenbuttel, BHR Heidendal, GA Saris, WHM
Citation: Ee. Blaak et al., Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes, CLIN SCI, 97(4), 1999, pp. 421-428

Authors: Schoon, EJ Wolffenbuttel, BHR Stockbrugger, RW
Citation: Ej. Schoon et al., Osteoporosis as a risk in inflammatory bowel disease, DRUGS TODAY, 35, 1999, pp. 17-28

Authors: Oranje, WA Wolffenbuttel, BHR
Citation: Wa. Oranje et Bhr. Wolffenbuttel, Lipid peroxidation and atherosclerosis in type II diabetes, J LA CL MED, 134(1), 1999, pp. 19-32

Authors: Wolffenbuttel, BHR
Citation: Bhr. Wolffenbuttel, Rosiglitazone - A viewpoint by bruce H.R. Wolffenbuttel, DRUGS, 57(6), 1999, pp. 931-932
Risultati: 1-25 | 26-26